Vemircopan

N/A

Report date: 2025/01/10 20:00:59
NME

Base Information

Drug NameVemircopan
Drug Alias NameACH-0145228ACH-5228ALXN-2050
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement factor D inhibitors
TargetsComplement factor D
Therapy Area/IndicationsHemoglobinuria, ParoxysmalRenal InsufficiencyLupus Nephritis +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[19
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesAchillion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active IndicationsRenal Insufficiency
Inactive IndicationsHemoglobinuria, ParoxysmalLupus NephritisGlomerulonephritis, IGA +[5

Other Information

ATC CodeN/A
Related LinksN/A